Prof. Tabarés is a permanent Senior Professor of Psychiatry at the University of Valencia and is the Principal Investigator of both the Ministry of Science and Innovation’s Centre of Networked Biomedical Research in Mental Health (CIBERSAM; Centro de Investigación Biomédica en Red de Salud Mental) division and of one of the PROMETEO program’s R&D Excellence Groups. He is the Director of the Severe Mental Disorders Research Group at the University of Valencia, and Coordinator of the “Personal Autonomy, Dependence, and Severe Mental Disorders” Microcluster on the Valencia International Campus of Excellence (VLC/CAMPUS)—an initiative by the Ministry of Science and Innovation constituting a research unit. Prof. Tabarés is also a member of the Ministry of Health and Social Policy’s Expert Scientific Committee—the Institute for the Elderly and Social Services (IMSERSO; Instituto de Mayores y Servicios Sociales)—for applications to the Health and Social Care Referral Centre for people affected by severe mental disorders in Valencia. He is a member of the editorial and expert committee of several prestigious journals and has received multiple awards and acknowledgements; among them, the following stand out:
- He is a member of the highly-cited researchers list (HiCi indicator; Thomson-Reuters, 2013), a list which combines all the areas of knowledge constituted by 112 highly-cited researchers in Spain, of which five correspond to the University of Valencia.
- He received the Aristotle Research Award for the study: Mutations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar disorder: A preliminary study. 2nd International congress on BRAIN AND BEHAVIOUR, at the Grand Hotel Palace, Thessaloniki, Greece. 2005
- He received the Investigador de Referencia (Benchmark Researcher) award from the Spanish Society of Biological Psychiatry’s Research Excellence Program. IIIX National Congress of Psychiatry. Madrid 2009.
- In 2013 he was awarded the prize for best scientific research for his work entitled: “Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies” by the Valencian Autonomous Community’s Royal Academy of Medicine and Science (RAMCV; Reial Acadèmia de Medicina i Ciències de la Comunitat Valenciana).
• To study neurocognitive endophenotypes in schizophrenia and bipolar disorder.
• Study pharmacological strategies for improving cognitive function in bipolar disorder.
• Investigate the epidemiology and disability associated with severe mental illness (SMI)
• Identification of SMI biomarkers.
• Study the direct and inverse comorbidity in SMIs in relation to cancer and diabetes.
• Develop and study the efficacy of psychoeducation therapies and neurocognitive and functional rehabilitation for people with SMIs.
• Establish a clinical staging system applicable in bipolar disorder by identifying biomarker combinations and neurocognitive and functional performance markers.
Desire to subscribe to Incliva's newsletter.